Innovation and Entrepreneurship Award for University of Edinburgh and Nuvectis – we have now received a photograph of the winning team🙂 (courtesy of Cancer Research Horizons). Read the full story on our website: ed.ac.uk/cancer-centre/…

“Adjuvant pembrolizumab improves survival in high-risk clear cell renal cell cancer” – important update from the KEYNOTE-564 trial just published in NEJM ! Read a lay audience summary on our website 👇: ed.ac.uk/cancer-centre/…

If you are thinking about applying for MarieSkłodowskaCurie Postdoctoral Fellowship and are looking for great place to host your project consider contacting Edinburgh Cancer Research investigators! Some of them could support your application.

Congratulations to Prof Neil Carragher who has been elected as Fellow of the Royal Society of Edinburgh. Prof Carragher leads laboratory at Edinburgh Cancer Research Institute of Genetics and Cancer specializing in drug discovery and cell based screening technologies.
rse.org.uk/fellowship/pro…

Visit our website to read about Innovation and Entrepreneurship Award for University of Edinburgh (Edinburgh Cancer Research Institute of Genetics and Cancer researchers !) and Nuvectis 👇: ed.ac.uk/cancer-centre/…

📢 Attention #earlycareerresearcher at the Twitter University! EPSRC IAA is offering a personal award of up to £2,500 to develop an impact opportunity from your research. Register your interest now and we'll provide you with the application form! ➡️ed.ac.uk/edinburgh-inno…

#InTheNews Clinician scientists have a vital role to play by bringing their knowledge & experience of treating people with cancer to scientific research. We welcome that Scotland has received more than £7m to train the next generation of clinician scientists.…

Don't miss the poster from Neil Carragher on his research group's work with the novel YES1/SRC kinase inhibitor and its effect on proliferation in cell lines resistant to ALK and EGFR inhibitors.

📌 Stop by section 25 to learn more.

Edinburgh Cancer Research | Institute of Genetics and Cancer | #AACR24

“Development of Biocompatible Cu(I)-Microdevices for Bioorthogonal Uncaging and Click Reactions” – paper from our BOOMchemistry.com lab published in Chemistry – A European Journal Chemistry Europe👇:
…mistry-europe.onlinelibrary.wiley.com/doi/10.1002/ch…

The application deadline for the CRUK funded TRACC Programme MB-PhD positions has been extended till 16 April! Details in the picture below. Also available (including application form) at: ed.ac.uk/cancer-centre/…

Congratulations to former Edinburgh Cancer Research PhD student Jasmin Paris on being the first female ever to complete the grueling Barkley Marathon in Tennessee, USA.
bbc.co.uk/news/uk-scotla…

Congratulations to Nuvectis, The University of Edinburgh, University of Dundee, & Boehringer Ingelheim UK & Ireland for winning The Further, Faster Together Award at Cancer Research Horizons #IEAwards2024 .

A huge congratulations to Nuvectis, The University of Edinburgh , University of Dundee, & Boehringer Ingelheim UK & Ireland for winning The Further, Faster Together Award at Cancer Research Horizons #IEAwards2024 🎉

The Centre for Inflammation Research Edinburgh Cancer Research
#innovation #collaboration

🥇 The winners of the Further, Faster Together Award are… University of Dundee, Boehringer Ingelheim UK & Ireland The University of Edinburgh and Nuvectis – for a promising new approach to #PROTACs technologies.

#IEAwards24 #OnMyHorizon #ProteinDegradation #Nuvectis

Great to see this published this month.

Really enjoyed writing this with Prof Mark Arends (as part of our joint CRUK Scotland Centre) to give an update from a molecular pathology view of subtypes in CRC.

The Patrick G Johnston Centre for Cancer Research CRUK Scotland Inst Edinburgh Cancer Research The University of Edinburgh

link.springer.com/epdf/10.1007/s…

👇

Molecular pathological classification of colorectal cancer—an update, by Philip D. Dunne & Mark J. Arends. Just published in Virchows Archiv Annual Review Issue (Vol 484 (2), 2024). Molecular pathology as basis for timely cancer diagnosis and therapy. rdcu.be/dBJPt

Our fantastic zebrafish team are delivering a creative workshop for all the family on Fri 5 April at National Museums Scotland for Edinburgh Science. Join them for Zebrafish! A Splash of Science and Art. #EdinburghScienceFestival #EdSciFest ZebrafishHGU Info & tickets edinburghscience.co.uk/event/zebrafis…

“Variation in colorectal cancer treatment and outcomes in Scotland: real world evidence from national linked administrative health data” - Edinburgh Cancer Research investigators led a study providing new insights into outcomes of colorectal cancer patients in Scotland: ncbi.nlm.nih.gov/pmc/articles/P…

“Basal-epithelial subpopulations underlie and predict chemotherapy resistance in triple-negative breast cancer”: Edinburgh Cancer Research Institute of Genetics and Cancer researchers contributed to a study that sheds light on chemotherapy resistance in the most aggressive breast cancer type: embopress.org/doi/full/10.10…

'Circulating 25-hydroxyvitamin D and survival outcomes of colorectal cancer: evidence from population-based prospective cohorts and Mendelian randomisation' – study led by Edinburgh Cancer Research Institute of Genetics and Cancer researchers published in British Journal of Cancer 👇:
nature.com/articles/s4141…